|
|
Type 2 diabetic patients with non-alcoholic fatty liver disease exhibit significant haemorheological abnormalities |
Hui Dong1, Fu’er Lu1, Nan Wang2(), Xin Zou1, Jingjing Rao2 |
1. Institute of Integrative Traditional and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; 2. Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China |
|
|
Abstract Haemorheological abnormalities have been described in diabetes mellitus, as well as in non-alcoholic fatty liver disease (NAFLD). However, the relationship between the changes in liver fat content and haemorheology is unknown. The current study aims to show the correlation between haemorheological parameters and intrahepatic lipid content (IHLC) in patients with type 2 diabetes. The serum biochemical markers, such as fasting plasma glucose (FPG), haemoglobin A1c (HbA1c), liver enzymes, lipid profiles, and haemorheological properties, were examined. IHLC was quantified using proton magnetic resonance spectroscopy (1H-MRS) scanning of the liver. A significant correlation was observed between IHLC and whole blood viscosity at high, middle, and low shear rates. IHLC also positively correlated with haematocrit, the reduced whole blood viscosity at low and middle shear rates, and the erythrocyte aggregation index. Diabetic patients with NAFLD exhibited significant haemorheological abnormalities compared with patients without NAFLD. In summary, haemorheological disorders are linked to non-alcoholic fatty liver in type 2 diabetes.
|
Keywords
diabetes mellitus, type 2
haemorheology
non-alcoholic fatty liver disease
|
Corresponding Author(s):
Wang Nan,Email:southern1@sohu.com
|
Issue Date: 05 September 2011
|
|
1 |
Angulo P, Lindor KD. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2002; 17(Suppl): S186-S190 doi: 10.1046/j.1440-1746.17.s1.10.x pmid:12000605
|
2 |
Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, Day C, Arcaro G. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007; 30(5): 1212-1218 doi: 10.2337/dc06-2247 pmid:17277038
|
3 |
Le Dévéhat C, Vimeux M, Khodabandehlou T. Blood rheology in patients with diabetes mellitus. Clin Hemorheol Microcirc 2004; 30(3-4): 297-300 pmid:15258357
|
4 |
Ijaz S, Yang W, Winslet MC, Seifalian AM. Impairment of hepatic microcirculation in fatty liver. Microcirculation 2003; 10(6): 447-456 pmid:14745457
|
5 |
Sato N, Eguchi H, Inoue A, Matsumura T, Kawano S, Kamada T. Hepatic microcirculation in Zucker fatty rats. Adv Exp Med Biol 1986; 200: 477-483 pmid:3799339
|
6 |
Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J. Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362(12): 1090-1101 doi: 10.1056/NEJMoa0908292 pmid:20335585
|
7 |
Seifalian AM, Chidambaram V, Rolles K, Davidson BR. In vivo demonstration of impaired microcirculation in steatotic human liver grafts. Liver Transpl Surg 1998; 4(1): 71-77 doi: 10.1002/lt.500040110 pmid:9457970
|
8 |
Wang N, Dong H, Wei S, Lu F. Application of proton magnetic resonance spectroscopy and computerized tomography in the diagnosis and treatment of nonalcoholic fatty liver disease. J Huazhong Univ Sci Technolog Med Sci 2008; 28(3): 295-298 doi: 10.1007/s11596-008-0315-2 pmid:18563327
|
9 |
Dagnelie PC, Leij-Halfwerk S. Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer. World J Gastroenterol 2010; 16(13): 1577-1586 doi: 10.3748/wjg.v16.i13.1577 pmid:20355236
|
10 |
Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005; 288(2): E462-E468 doi: 10.1152/ajpendo.00064.2004 pmid:15339742
|
11 |
Nguyen DM, El-Serag HB. The epidemiology of obesity. Gastroenterol Clin North Am 2010; 39(1): 1-7 doi: 10.1016/j.gtc.2009.12.014 pmid:20202574
|
12 |
Seifalian AM, Piasecki C, Agarwal A, Davidson BR. The effect of graded steatosis on flow in the hepatic parenchymal microcirculation. Transplantation 1999; 68(6): 780-784 doi: 10.1097/00007890-199909270-00009 pmid:10515377
|
13 |
Longo R, Pollesello P, Ricci C, Masutti F, Kvam BJ, Bercich L, Crocè LS, Grigolato P, Paoletti S, de Bernard B, Tiribelli C, Dalla Palma L. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 1995; 5(3): 281-285 doi: 10.1002/jmri.1880050311 pmid:7633104
|
14 |
Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD, Stein DT. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 1999; 276(5 Pt 1): E977-E989 pmid:10329993
|
15 |
Westerbacka J, Cornér A, Tiikkainen M, Tamminen M, Vehkavaara S, H?kkinen AM, Fredriksson J, Yki-J?rvinen H. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia 2004; 47(8): 1360-1369 15309287 doi: 10.1007/s00125-004-1460-1
|
16 |
Schick F, Eismann B, Jung WI, Bongers H, Bunse M, Lutz O. Comparison of localized proton NMR signals of skeletal muscle and fat tissue in vivo: two lipid compartments in muscle tissue. Magn Reson Med 1993; 29(2): 158-167 doi: 10.1002/mrm.1910290203 pmid:8429779
|
17 |
Dong H, Lu FE, Wang N, Xu LJ, Zou X, Rao JJ. Factors related with hepatic triglyceride contents in patients with type 2 diabetes: a magnetic resonance spectroscopy study. J Huazhong Univ Sci Technol Med Sci 2010; 39(1): 64-68
|
18 |
Sam S, Haffner S, Davidson MH, D’Agostino RB Sr, Feinstein S, Kondos G, Perez A, Mazzone T. Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes. Diabetes 2008; 57(8): 2022-2027 doi: 10.2337/db08-0157 pmid:18469202
|
19 |
Farrell GC, Teoh NC, McCuskey RS. Hepatic microcirculation in fatty liver disease. Anat Rec (Hoboken) 2008; 291(6): 684-692 doi: 10.1002/ar.20715 pmid:18484615
|
20 |
Negrean V, Suciu I, Sampelean D, Cozma A. Rheological changes in diabetic microangiopathy. Rom J Intern Med 2004; 42(2): 407-413 pmid:15529630
|
21 |
Martins e Silva J, Saldanha C. Cardiovascular risk factors: hemorheologic and hemostatic components. Rev Port Cardiol 2007; 26(2): 161-182 pmid:17479711
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|